Does Acanthosis Nigricans Go Away? What Actually Fades It

Does acanthosis nigricans actually go away?

Yes, but only in the sense that the skin change reverses as its cause improves — it is not a permanent mark, and it is not scar tissue. A 2004 pathophysiology review states plainly that control of obesity contributes largely to reversing the whole process, mainly by reducing insulin resistance and the compensatory high insulin levels driving it. That is the honest starting point: the fastest route to fading the patch runs through the insulin level that caused it, and topical treatment on its own manages the visible surface while that deeper work happens.

Two separate questions get asked under the same search — “how to get rid of acanthosis nigricans” — and they have different answers. If the question is about the visible patch, a topical treatment with actual trial evidence behind it is the answer below. If the question is about the condition returning again and again despite creams, the answer is that nothing applied to the skin addresses insulin resistance, and the patch will keep coming back until that number changes.

What actually fades it — the trial evidence

A 2025 systematic review pooled seven randomized controlled trials — 268 people in total — testing topical treatments on the neck and axillae over 8 weeks to 2 months, and found real differences between options rather than a single clear winner. Tretinoin (0.025–0.05%) reduced dark pigmentation more than any other treatment tested, and patients reported higher satisfaction with it than with glycolic acid peels. Urea cream (10–20%) worked best on redness and irritation rather than pigment, with the 20% strength showing the strongest effect. Salicylic acid 10% performed similarly to urea, with milder side effects. Among the chemical peels, a 15% trichloroacetic acid peel outperformed a 35% glycolic acid peel on both skin improvement and patient satisfaction after eight weeks.

All treatments in the review carried mild, self-limited side effects — stinging, dryness or peeling — and none required stopping treatment. The trials ran 8 weeks to 2 months, which is the realistic minimum before you should expect to see a visible difference from a topical alone.

Why metformin is not a skin treatment

Metformin treats insulin resistance; it does not reliably treat the patch itself. A 12-week randomized pilot study put overweight or obese adults with acanthosis nigricans on either metformin (n=4) or rosiglitazone (n=3), and found no effect on the severity of the acanthosis nigricans in either group, even though rosiglitazone did significantly lower insulin levels. Both groups saw only modest improvement in skin texture. The lesson from a study this small is limited, but it lines up with the mechanism: metformin lowers circulating insulin over months, while the epidermal thickening already present took months or years to build and does not reverse just because the signal driving it has dropped. Metformin’s broader role in PCOS — where it helps and where the evidence is weak — is covered separately.

The combination that outperforms either approach alone

Topical retinoids are considered first-line treatment for the hyperpigmented plaques, with skin irritation as the main limiting factor — which is exactly why combination approaches exist. A 2025 review of combinational treatment strategies for acanthosis nigricans describes pairing a retinoid with a gentler agent such as urea to offset irritation while keeping the pigment-fading effect, rather than choosing one option and stopping there. Practically, that means addressing the underlying insulin resistance — through the changes covered in insulin resistance and PCOS — while a topical works on the visible surface at the same time, instead of waiting for one approach to finish before starting the other.

Who this will not work for

Topical treatment and weight-related improvement will not resolve every case, and it is worth knowing which one you have before spending months on a routine that was never going to work:

• A rare hereditary form in children and adolescents with no metabolic disease does not respond to insulin-focused treatment because insulin resistance was never the cause. It generally needs no treatment at all beyond cosmetic preference.
• Deeper native skin tone in the affected fold is not something a lightening treatment will change, because there may be no excess pigment to remove — only genuine texture change responds.
• Sudden, rapidly progressing acanthosis nigricans in an older adult, especially with unexplained weight loss or mouth involvement, will not respond to any of the treatments above, because it signals the rare paraneoplastic form. That needs a cause found, not a cream tried.
• Hydroquinone, bleaching kits, and home exfoliation have no trial evidence behind them for this specific condition and are not what the studies above tested — do not substitute them for the options with actual data.
• Stopping treatment as soon as the skin looks better does not hold the result if the insulin resistance behind it is unchanged. The trials measured improvement while treatment continued; none of them followed people after stopping to see how long the fading lasts.

Note: in May 2026, PCOS was renamed polyendocrine metabolic ovarian syndrome, or PMOS, by a global consensus of more than 50 organisations. Same condition, same insulin-driven mechanism behind acanthosis nigricans — only the label changed. This article uses PCOS, since that is still the term most readers search.

Your next step

If the goal is fading what is already visible, ask a dermatologist about tretinoin or a urea-based cream and give it the full 8-week course before judging it — that is the minimum window the trial evidence used. If the goal is addressing why it appeared, a fasting insulin and glucose panel is the more useful next step than any cream; what causes it in the first place is covered here, and if you are also noticing skin tags in the same folds, the two are worth mentioning to your doctor together.